Balduzzi, A. (2017). Minimal residual disease assessment by next-generation sequencing. Better tools to gaze into the crystal ball?. BONE MARROW TRANSPLANTATION, 52(7), 952-954 [10.1038/bmt.2017.104].

Minimal residual disease assessment by next-generation sequencing. Better tools to gaze into the crystal ball?

Balduzzi, A
2017

Articolo in rivista - Articolo scientifico
Humans; High-Throughput Nucleotide Sequencing; Neoplasm, Residual; Hematology; Transplantation
English
2017
52
7
952
954
reserved
Balduzzi, A. (2017). Minimal residual disease assessment by next-generation sequencing. Better tools to gaze into the crystal ball?. BONE MARROW TRANSPLANTATION, 52(7), 952-954 [10.1038/bmt.2017.104].
File in questo prodotto:
File Dimensione Formato  
Balduzzi-2017-Bone Marrow Transplant-VoR.pdf

Solo gestori archivio

Descrizione: Commentary
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 107.3 kB
Formato Adobe PDF
107.3 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/221930
Citazioni
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
Social impact